Xenoglim-MP1 Tablet ER

Overview Xenoglim-MP1 Tablet ER

Glycemia-Control XR is a dual-action tablet formulated to manage blood glucose. This medication, used alongside diet and physical activity, enhances blood sugar regulation in adult patients with type 2 diabetes. It promotes efficient insulin use, consequently reducing elevated blood sugar. Always adhere to your physician's prescribed dosage and regimen for Glycemia-Control XR. Take it with food to minimize digestive discomfort. If a dose is missed, take it promptly; however, if the next dose is imminent, omit the missed one and resume your regular schedule. Never double the dose. Excessive intake can result in hypoglycemia (low blood sugar). Concomitant use with other antidiabetic medications, alcohol, or missed meals may increase the risk of hypoglycemia. Regular blood glucose monitoring is essential during treatment. Commonly reported side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, inform your doctor of any pre-existing kidney, liver, or heart conditions. Pregnant or lactating individuals should consult their physician before use. Kidney function tests will be assessed by your doctor before initiating therapy. Limit alcohol consumption as it may heighten the likelihood of adverse effects.

Uses of Xenoglim-MP1 Tablet ER

Managing type 2 diabetes

Major Benefits of Xenoglim-MP1 Tablet ER:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the Xenoglim-MP1 Tablet ER whole; avoid chewing, crushing, or fracturing it. It should be taken with a meal.

Common Side effects of Xenoglim-MP1 Tablet ER:

• Hypoglycemia (low blood glucose level)
• Headache
• Nausea
• Diarrhea
• Dizziness
• Vomiting
• Anemia (low number of red blood cells)
• Weakness
• Sinus infection

How to use Xenoglim-MP1 Tablet ER:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the Xenoglim-MP1 Tablet ER whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

How Xenoglim-MP1 Tablet ER works:

Xenoglim-MP1 Extended-Release tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. These medications employ diverse mechanisms to achieve superior blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood glucose levels. Metformin, a biguanide, acts by diminishing hepatic glucose production, retarding intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further amplifies insulin sensitivity.

What if you forget to take Xenoglim-MP1 Tablet ER :

Should you forget a Xenoglim-MP1 Extended-Release Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.